BioAtla, Inc.
BCAB
$4.54
$0.020.44%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -31.37% | -41.82% | -15.52% | -34.46% | -48.62% |
| Gross Profit | 48.54% | -76.81% | 15.52% | 34.46% | 48.62% |
| SG&A Expenses | -29.04% | -27.66% | -14.05% | -6.17% | -21.63% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -30.71% | -38.08% | -15.13% | -27.98% | -43.08% |
| Operating Income | 43.03% | -22.35% | 15.13% | 27.98% | 43.08% |
| Income Before Tax | 34.26% | -49.05% | 11.20% | 34.00% | 44.72% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 34.26% | -49.05% | 11.20% | 34.00% | 44.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 34.26% | -49.05% | 11.20% | 34.00% | 44.72% |
| EBIT | 43.03% | -22.35% | 15.13% | 27.98% | 43.08% |
| EBITDA | 42.33% | -24.37% | 14.77% | 28.02% | 43.14% |
| EPS Basic | 45.41% | -22.63% | 26.82% | 45.52% | 46.57% |
| Normalized Basic EPS | 45.41% | -22.64% | 26.82% | 45.52% | 46.57% |
| EPS Diluted | 45.41% | -22.63% | 26.82% | 45.52% | 46.57% |
| Normalized Diluted EPS | 45.41% | -22.64% | 26.82% | 45.52% | 46.57% |
| Average Basic Shares Outstanding | 20.42% | 21.54% | 21.34% | 21.14% | 3.47% |
| Average Diluted Shares Outstanding | 20.42% | 21.54% | 21.34% | 21.14% | 3.47% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |